<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Reduced dietary salt for the prevention of cardiovascular disease - Adler, AJ - 2014 | Cochrane Library</title> <meta content="Reduced dietary salt for the prevention of cardiovascular disease - Adler, AJ - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009217.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Reduced dietary salt for the prevention of cardiovascular disease - Adler, AJ - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009217.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009217.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Reduced dietary salt for the prevention of cardiovascular disease" name="citation_title"/> <meta content="Alma J Adler" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="alma.adler@lshtm.ac.uk" name="citation_author_email"/> <meta content="Fiona Taylor" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="Nicole Martin" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Sheldon Gottlieb" name="citation_author"/> <meta content="Johns Hopkins Bay View Medical Centre" name="citation_author_institution"/> <meta content="Rod S Taylor" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Shah Ebrahim" name="citation_author"/> <meta content="London School of Hygiene &amp; Tropical Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD009217.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/12/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009217.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009217.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009217.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Diet, Sodium‐Restricted; Cardiovascular Diseases [mortality, *prevention &amp; control]; Hypertension [mortality]; Randomized Controlled Trials as Topic; Sodium Chloride, Dietary [*administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009217.pub3&amp;doi=10.1002/14651858.CD009217.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="7a2tKMcJ";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009217\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009217\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ko","ms","ja","hr","pl","ta","zh_HANS","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009217.pub3",title:"Reduced dietary salt for the prevention of cardiovascular disease",firstPublishedDate:"Dec 18, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009217.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009217.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009217.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009217.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009217.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009217.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009217.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009217.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009217.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009217.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17649 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009217.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0043"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0044"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0045"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0063"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/appendices#CD009217-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/table_n/CD009217StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/table_n/CD009217StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Reduced dietary salt for the prevention of cardiovascular disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Alma J Adler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0003">Fiona Taylor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0004">Nicole Martin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0005">Sheldon Gottlieb</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0006">Rod S Taylor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information#CD009217-cr-0007">Shah Ebrahim</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information/en#CD009217-sec-0114">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 December 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009217.pub3">https://doi.org/10.1002/14651858.CD009217.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009217-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009217-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009217-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009217-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009217-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009217-abs-0002">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009217-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009217-abs-0001" lang="en"> <section id="CD009217-sec-0001"> <h3 class="title" id="CD009217-sec-0001">Background</h3> <p>This is an update of a Cochrane review that was first published in 2011 of the effects of reducing dietary salt intake, through advice to reduce salt intake or low‐sodium salt substitution, on mortality and cardiovascular events. </p> </section> <section id="CD009217-sec-0002"> <h3 class="title" id="CD009217-sec-0002">Objectives</h3> <p>1. To assess the long‐term effects of advice and salt substitution, aimed at reducing dietary salt, on mortality and cardiovascular morbidity. </p> <p>2. To investigate whether a reduction in blood pressure is an explanatory factor in the effect of such dietary interventions on mortality and cardiovascular outcomes. </p> </section> <section id="CD009217-sec-0003"> <h3 class="title" id="CD009217-sec-0003">Search methods</h3> <p>We updated the searches of CENTRAL (2013, Issue 4), MEDLINE (OVID, 1946 to April week 3 2013), EMBASE (OVID, 1947 to 30 April 2013) and CINAHL (EBSCO, inception to 1 April 2013) and last ran these on 1 May 2013. We also checked the references of included studies and reviews. We applied no language restrictions. </p> </section> <section id="CD009217-sec-0004"> <h3 class="title" id="CD009217-sec-0004">Selection criteria</h3> <p>Trials fulfilled the following criteria: (1) randomised, with follow‐up of at least six months, (2) the intervention was reduced dietary salt (through advice to reduce salt intake or low‐sodium salt substitution), (3) participants were adults and (4) mortality or cardiovascular morbidity data were available. Two review authors independently assessed whether studies met these criteria. </p> </section> <section id="CD009217-sec-0005"> <h3 class="title" id="CD009217-sec-0005">Data collection and analysis</h3> <p>A single author extracted data and assessed study validity, and a second author checked this. We contacted trial authors where possible to obtain missing information. We extracted events and calculated risk ratios (RRs) and 95% confidence intervals (CIs). </p> </section> <section id="CD009217-sec-0006"> <h3 class="title" id="CD009217-sec-0006">Main results</h3> <p>Eight studies met the inclusion criteria: three in normotensives (n = 3518) and five in hypertensives or mixed populations of normo‐ and hypertensives (n = 3766). End of trial follow‐up ranged from six to 36 months and the longest observational follow‐up (after trial end) was 12.7 years. </p> <p>The risk ratios (RR) for all‐cause mortality in normotensives were imprecise and showed no evidence of reduction (end of trial RR 0.67, 95% confidence interval (CI) 0.40 to 1.12, 60 deaths; longest follow‐up RR 0.90, 95% CI 0.58 to 1.40, 79 deaths n=3518) or in hypertensives (end of trial RR 1.00, 95% CI 0.86 to 1.15, 565 deaths; longest follow‐up RR 0.99, 95% CI 0.87 to 1.14, 674 deaths n=3085).  </p> <p>There was weak evidence of benefit for cardiovascular mortality (hypertensives: end of trial RR 0.67, 95% CI 0.45 to 1.01, 106 events n=2656) and for cardiovascular events (hypertensives: end of trial RR 0.76, 95% CI 0.57 to 1.01, 194 events, four studies, n = 3397; normotensives: at longest follow‐up RR 0.84, 95% CI 0.64 to 1.10, 200 events; hypertensives: RR 0.77, 95% CI 0.58 to 1.02, 192 events; pooled analysis of six trials (RR 0.81, 95% CI 0.66 to 0.98; n = 5762). These findings were driven by one trial among retirement home residents that reduced salt intake in the kitchens of the homes, thereby not requiring individual behaviour change. </p> <p>Advice to reduce salt showed small reductions in systolic blood pressure (mean difference (MD) ‐1.15 mmHg, 95% CI ‐2.32 to 0.02 n=2079) and diastolic blood pressure (MD ‐0.80 mmHg, 95% CI ‐1.37 to ‐0.23 n=2079) in normotensives and greater reductions in systolic blood pressure in hypertensives (MD ‐4.14 mmHg, 95% CI ‐5.84 to ‐2.43 n=675), but no difference in diastolic blood pressure (MD ‐3.74 mmHg, 95% CI ‐8.41 to 0.93 n=675). </p> <p>Overall many of the trials failed to report sufficient detail to assess their potential risk of bias. Health‐related quality of life was assessed in one trial in normotensives, which reported significant improvements in well‐being but no data were presented. </p> </section> <section id="CD009217-sec-0007"> <h3 class="title" id="CD009217-sec-0007">Authors' conclusions</h3> <p>Despite collating more event data than previous systematic reviews of randomised controlled trials, there is insufficient power to confirm clinically important effects of dietary advice and salt substitution on cardiovascular mortality in normotensive or hypertensive populations. Our estimates of the clinical benefits from advice to reduce dietary salt are imprecise, but are larger than would be predicted from the small blood pressure reductions achieved. Further well‐powered studies would be needed to obtain more precise estimates. Our findings do not support individual dietary advice as a means of restricting salt intake. It is possible that alternative strategies that do not require individual behaviour change may be effective and merit further trials. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009217-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009217-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009217-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009217-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009217-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009217-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009217-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009217-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009217-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009217-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ta#CD009217-abs-0012">தமிழ்</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009217-abs-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009217-abs-0018">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009217-abs-0005" lang="en"> <h3>Reduced dietary salt for the prevention of cardiovascular disease</h3> <p>Cardiovascular disease includes heart attacks and strokes and is a major cause of premature death and disability. This is an update of a review first published in 2011. This review sets out to assess whether intensive support and encouragement to cut down on salt in foods, and substituting low‐sodium salt, reduces the risk of death or cardiovascular disease. This update includes two new studies and eliminates one problematic study, giving a total of eight trials with 7284 participants. </p> <p>Dietary advice and salt substitution did reduce the amount of salt eaten, which led to a small reduction in blood pressure by six months. There was weak evidence of benefit for cardiovascular events, but these findings were inconclusive and were driven by a single trial among retirement home residents, which reduced salt intake in the kitchens of the homes. </p> <p>The findings of our review do not mean that advising people to reduce salt should be stopped. However, additional measures ‐ reducing the amount of hidden salt in processed foods, for example – will make it much easier for people to achieve a lower salt diet. Overall many of the trials failed to report sufficient detail to assess their potential risk of bias. Further evidence of the effects of different ways of reducing dietary salt on clinical events is needed from experimental and observational studies to underpin public health policies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009217-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009217-sec-0087"></div> <h3 class="title" id="CD009217-sec-0088">Implications for practice</h3> <section id="CD009217-sec-0088"> <p>Despite collating more event data than previous systematic reviews of randomised controlled trials, there is insufficient power to confirm clinically important effects of dietary advice and salt substitution on cardiovascular mortality in normotensive or hypertensive populations. The methods of achieving salt reduction (advice and salt substitution) in the trials included in our review, and other systematic reviews, were relatively modest in their impact on sodium excretion and on blood pressure levels. They generally required considerable efforts to implement and would not be expected to have an effect on the burden of cardiovascular disease commensurate with their costs. The challenge for clinical and public health practice is to find more effective interventions for reducing salt intake that are both practicable and inexpensive. </p> <p>Many countries have national authoritative recommendations, often sanctioned by government, which call for reduced dietary sodium. In the UK, the National Institute of Health and Care Excellence (NICE) has recently called for an acceleration of the reduction in salt intake of the general population from a maximum intake of 6 g per day per adult by 2015 to 3 g by 2025 (<a href="./references#CD009217-bbs2-0062" title="National Institute for Health &amp; Clinical Excellence (NICE). Prevention of cardiovascular disease at population level. Public health guidance 25. www.nice.org.uk/guidance/PH25 (accessed 31 May 2011). ">NICE 2010</a>). </p> </section> <h3 class="title" id="CD009217-sec-0089">Implications for research</h3> <section id="CD009217-sec-0089"> <p>Further long‐term follow‐up of existing trials (as done by Trials of Hypertension Prevention (TOHP) I, TOHP II and Trial of Nonpharmacologic Intervention in the Elderly (TONE)) may contribute further events to allow assessment of the long‐term effects of reduced dietary salt advice on mortality, cardiovascular morbidity and hormonal and lipid outcomes, although the intensive dietary advice interventions evaluated in trials over the last three decades are of less relevance to current policy initiatives. Our findings support the recent US Institute of Medicine recommendation for further rigorous, large, long‐term studies, capable of demonstrating the cardiovascular benefit of dietary salt reduction beyond reasonable doubt using a range of plausible interventions. Such trials need to assess <i>population level</i> (e.g. workplace, institutional, regulatory) interventions that might be more likely to lead to sustained reductions in salt intake and which would provide evidence relevant to current public health guidelines. It will also be important to evaluate the effects of voluntary and regulatory salt reduction by food industries (such as the UK's reduction of salt in processed foods) on dietary salt intake and blood pressure, as these may hold greater opportunities for practicable and inexpensive means of reducing salt intake in the population at large. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009217-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009217-sec-0043"></div> <p>In 2010 it was estimated that nearly 12.9 million deaths (a quarter of the global total) were due to ischaemic heart disease and stroke (<a href="./references#CD009217-bbs2-0052" title="LozanoR , NaghaviM , ForemanK , LimS , ShibuyaK , AboyansV , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2095‐128. ">Lozano 2012</a>). Morbidity data are more difficult to collect because there are so many different measures of cardiovascular morbidity. However, in 2010 ischaemic heart disease was globally the number one cause of disability adjusted life years (DALYs) lost each year, with nearly 130 million DALYs (<a href="./references#CD009217-bbs2-0021" title="AllenderS , ScarboroughP , PetoV , RaynerM , LealJ , Luengo‐FernandezR , et al. European Cardiovascular Disease Statistics 2008. 3rd Edition. European Heart Network, 2008. ">Allender 2008</a>). Similarly, high blood pressure was the number one risk factor, with over 170 million DALYs lost globally each year (<a href="./references#CD009217-bbs2-0060" title="MurrayCJL , LopezAD . Measuring the global burden of disease. New England Journal of Medicine2013;369:448‐57. ">Murray 2013</a>). </p> <p>Globally, high blood pressure is a leading risk factor for cardiovascular disease, contributing over 7% of the global DALYs in 2010 (<a href="./references#CD009217-bbs2-0051" title="LimS , VosT , FlaxmanA , DanaeiG , ShibuyaK , Adair‐RohaniH , et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990—2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380:2224‐60. ">Lim 2012</a>). The relationship of salt intake to blood pressure is the basis for the belief that restriction of dietary sodium intake will prevent blood pressure‐related cardiovascular events (<a href="./references#CD009217-bbs2-0035" title="ElliottP , StamlerJ , NicholsR , DyerAR , StamlerR , KestelootH , MarmotM . Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ1996;312(7041):1249‐53. ">Elliot 1996</a>). The public health recommendations of a decade ago remain in place: to reduce salt intake by about half, i.e. from approximately 10 to 5 g/day (<a href="./references#CD009217-bbs2-0031" title="U.S. Department of Agriculture and U.S. Department of Health &amp; Human Services. Dietary Guidelines for Americans, 2010. Washington DC: US Government Printing Office, December 2010. ">Dietary Guidelines for Americans 2010</a>; <a href="./references#CD009217-bbs2-0039" title="HeFJ , MacGregorGA . Reducing population salt intake worldwide: from evidence to implementation. Progress in Cardiovascular Diseases2010;52(5):363‐82. ">He 2010</a>; <a href="./references#CD009217-bbs2-0066" title="Scientific Advisory Committee on Nutrition (SACN). Salt and health. https://www.gov.uk/government/publications/sacn‐salt‐and‐health‐report (assessed 31 May 2011). ">SACN 2003</a>; <a href="./references#CD009217-bbs2-0073" title="WheltonPK , HeJ , AppelLJ , CutlerJA , HavasS , KotchenTA , et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA2002;288:1882‐8. ">Whelton 2002</a>; <a href="./references#CD009217-bbs2-0074" title="WheltonPK , AppelLJ , SaccoRL , AndersonCAM , AntmanEM , CampbellN , et al. Sodium, blood pressure and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation2012;126(24):2880‐9. ">Whelton 2012</a>), and they have also been endorsed in current World Health Organization guidelines on sodium intake (<a href="./references#CD009217-bbs2-0076" title="World Health Organization. Guideline: Sodium intake for adults and children. Geneva: WHO, 2012. ">WHO 2012</a>). </p> <p>Data from observational studies have indicated that a high dietary intake of salt is an important risk factor for cardiovascular disease (<a href="./references#CD009217-bbs2-0037" title="HeJ , WheltonPK . Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge. International Journal of Epidemiology2002;31:327‐31. ">He 2002</a>; <a href="./references#CD009217-bbs2-0039" title="HeFJ , MacGregorGA . Reducing population salt intake worldwide: from evidence to implementation. Progress in Cardiovascular Diseases2010;52(5):363‐82. ">He 2010</a>). Short‐term intervention studies, including the Dietary Approaches to Stop Hypertension (DASH) trials, have shown decreases in systolic blood pressure in all groups (<a href="./references#CD009217-bbs2-0065" title="SacksFM , SvetkeyLP , VollmerWM , AppelLJ , BrayGA , HarshaD , et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH‐Sodium Collaborative Research Group. New England Journal of Medicine2001;344(1):3‐10. ">Sacks 2001</a>). This was confirmed by a systematic review and meta‐analysis of 13 prospective studies including 177,000 participants, which reported a greater risk of stroke in those with higher salt intakes (relative risk 1.23, 95% CI 1.06 to 1.43) (<a href="./references#CD009217-bbs2-0069" title="StrazzulloP , D'EliaL , KandalaNB , CappuccioFP . Salt intake, stroke, and cardiovascular disease: meta‐analysis of prospective studies. BMJ2009;339:b4567. ">Strarzzullo 2009</a>). However, in this review the association between salt intake and all cardiovascular events was smaller (relative risk 1.14, 95% CI 0.99 to 1.31) and with the exclusion of one study statistical significance was achieved (relative risk 1.17, 95% CI 1.02 to 1.32), but all‐cause mortality was not reported. The interpretation of this observational evidence base is complicated by the heterogeneity in estimating sodium intake (diet or urinary salt excretion), types of participants (healthy, hypertensive, obese and non‐obese), endpoints and the definition of outcomes across studies (<a href="./references#CD009217-bbs2-0018" title="AldermanMH . Reducing dietary sodium. The case for caution. JAMA2010;303:448‐9. ">Alderman 2010</a>). A more recent review of observational studies reported no strong evidence of an effect on all‐cause mortality (relative risk 1.06, 95% CI 0.94 to 1.20) and similar inconclusive effects on cardiovascular disease (relative risk 1.12, 95% CI 0.93 to 1.34), noting that the quality of evidence was generally low due to non‐randomised designs (<a href="./references#CD009217-bbs2-0017" title="AburtoNJ , ZiolkovskaA , HooperL , ElliottP , CappuccioF , MeerpholJJ . Effect of lower sodium intake on health: systematic review and meta‐analyses. BMJ2013;346:f1326. ">Aburto 2013</a>). </p> <p>Following publication of the 2011 Cochrane review, commentators have put forward a view that the relationship between dietary sodium intake and cardiovascular events may be J‐shaped, suggesting that lowering sodium beyond a certain point may not be beneficial (<a href="./references#CD009217-bbs2-0019" title="AldermanMH . The Cochrane review of sodium and health. American Journal of Hypertension2011;24:854‐6. ">Alderman 2011</a>; <a href="./references#CD009217-bbs2-0020" title="AldermanMH , CohenHW . Dietary sodium intake and cardiovascular mortality: controversy resolved?. American Journal of Hypertension2012;25:727‐34. ">Alderman 2012</a>; <a href="./references#CD009217-bbs2-0056" title="MenteA , O'DonnellMJ , YusufS . Extreme sodium reductions for the entire population: zealotry or evidence based?. American Journal of Hypertension2013;26:1187‐90. ">Mente 2013</a>). Several prospective cohort studies have been published recently that overcome the problem of dietary sodium assessment by using urinary sodium excretion as an index of dietary intake. These have shown a possible J‐shaped relationship: low sodium intake (&lt; 3 g/day) is associated with no lower rate of cardiovascular disease, and perhaps a higher rate (<a href="./references#CD009217-bbs2-0033" title="EkinciE , ClarkeS , ThomasM , MoranJL , CheongK , MaclsaacRJ , et al. Dietary sodium intake and mortality in patients with type 2 diabetes. Diabetes Care2011;34:703‐9. ">Ekinci 2011</a>; <a href="./references#CD009217-bbs2-0063" title="O'DonnellMJ , YusufS , MenteA , GaoP , MannJF , TeoK , et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA2011;306:2229‐38. ">O'Donnell 2011</a>; <a href="./references#CD009217-bbs2-0068" title="Stolarz‐SkrzypekK , KuznetsovaT , ThijsL , TikhonoffV , SeidlerovaJ , RichartT , et al. Fatal and non‐fatal outcomes, incidence of hypertension and blood pressure changes in relation to urinary sodium excretion. JAMA2011;305(1777‐85). ">Stolarz‐Skrzypek 2011</a>). In light of these studies, the US Institute of Medicine reviewed the evidence and found that it supported population‐based efforts to lower excessive dietary salt intake, but not the lowering of intakes to &lt; 2.3 g sodium/day (<a href="./references#CD009217-bbs2-0046" title="IOM (Institute of Medicine). Sodium Intake in Populations: Assessment of Evidence. Washington DC: The National Academies Press, 2013. ">Institute of Medicine 2013</a>). Commentary on the new recommendations has suggested that the scientific debates, our earlier Cochrane review and difficulties in interpreting the evidence only provide opportunities for the food industry to avoid regulation of salt in their products (<a href="./references#CD009217-bbs2-0061" title="NealB , LandM‐A , WoodwardM . An update on the salt wars ‐ genuine controversy, poor science, or vested interest. Current Hypertension Reports2013;15(6):687‐93. ">Neal 2013</a>). Others consider that we still have insufficient evidence to decide whether to advise people to reduce their salt intake below current average levels (<a href="./references#CD009217-bbs2-0056" title="MenteA , O'DonnellMJ , YusufS . Extreme sodium reductions for the entire population: zealotry or evidence based?. American Journal of Hypertension2013;26:1187‐90. ">Mente 2013</a>). A recent review of four decades of the salt and health debate concludes that the evidence available from different eras has been unable to resolve the debate satisfactorily (<a href="./references#CD009217-bbs2-0024" title="BayerR , JohnsDM , GaleaS . Salt and public health: contested science and the challenge of evidence‐based decision making. Health Affairs2012;31:2738‐46. ">Bayer 2012</a>). </p> <p>A number of meta‐analyses of randomised controlled trials of salt reduction and blood pressure have been undertaken (<a href="./references#CD009217-bbs2-0038" title="HeFJ , MacGregorGA . Effect of longer‐term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD004937] ">He 2004</a>; <a href="./references#CD009217-bbs2-0048" title="JürgensG , GraudalNA . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD004022.pub2] ">Jürgens 2004</a>). Whilst these analyses consistently report a reduction in the level of blood pressure with reduced salt intake, the level of blood pressure reduction achieved is less impressive in the longer term. The 2004 Cochrane review of dietary salt restriction intervention studies of at least six months' duration found that intensive support and encouragement to reduce salt intake lowered blood pressure at 13 to 60 months, but only by a small amount (systolic by 1.1 mmHg, 95% CI 1.8 to 0.4; diastolic by 0.6 mmHg, 95% CI 1.5 to ‐0.3) (<a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>). These findings of small blood pressure reductions among normotensive people were confirmed in a recent Cochrane review, which demonstrated much smaller blood pressure reductions in normotensives (about 1% in systolic blood pressure) and greater reductions in hypertensive people (around 3.5%) (<a href="./references#CD009217-bbs2-0036" title="GraudalNA , Hubeck‐GraudalT , JurgensG . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD004022.pub3] ">Graudal 2011</a>). Certainly the very large estimated effects of salt reduction using both trial and observational data are no longer considered plausible (<a href="./references#CD009217-bbs2-0049" title="LawMR , FrostCD , WaldNJ . By how much does dietary salt reduction lower blood pressure? I‐‐Analysis of observational data among populations. BMJ1991;302:811‐5. ">Law 1991</a>). The most recent review has continued the questionable practice of combining both short and longer duration trials: among 34 trials of 3230 participants with four or more weeks (median four to five weeks) of follow‐up, the mean change in blood pressure was ‐4 mmHg for systolic and ‐2 mmHg for diastolic blood pressure, although heterogeneity was marked with I² estimates of between 68% and 75% (<a href="./references#CD009217-bbs2-0041" title="HeF , LiJ , MacGregorG A . Effect of longer‐term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews2013, Issue 4. [DOI: 10.1002/14651858.CD004937.pub2] ">He 2013a</a>; <a href="./references#CD009217-bbs2-0042" title="HeFJ , LiJ , MacGregorGA . Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta‐analysis of randomized trals. BMJ2013;346:f1325. ">He 2013b</a>). Such estimates are unlikely to reflect the reductions in blood pressure that can be obtained in the general normotensive population in practice. However, even small sustained reductions in mean blood pressure of 2 to 3 mmHg would be sufficient for important population reductions in cardiovascular events (<a href="./references#CD009217-bbs2-0034" title="ElliotP . Sodium and blood pressure: a review of the evidence from controlled trials of sodium reduction and epidemiological studies. Klinische Wochenschrift1991;69(Suppl 25):3‐10. ">Elliot 1991</a>). </p> <p>In a previous version of this review a trial of salt restriction in patients with heart failure was included (<a href="./references#CD009217-bbs2-0064" title="PaternaS , GaspareP , FasulloS , SarulloFM , DiPasqualeP . Normal‐sodium diet compared with low‐sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?. Clinical Science2008;114:221‐30. ">Paterna 2008</a>). We have now excluded this trial following the retraction by the editors of <i>Heart</i> journal of a meta‐analysis including this paper (<a href="./references#CD009217-bbs2-0032" title="Note ofRetraction . Heart Online first: 12 March 2013; Vol. 10.1136/heartjnl‐2012‐302337. ">Editor's Note 2013</a>). Trials of salt restriction in heart failure are no longer within the scope of this review. </p> <p>Whilst our earlier Cochrane review also sought to assess the impact of dietary salt restriction advice on mortality and cardiovascular events, across the 11 randomised controlled trials included there were only 17 deaths spread evenly across groups and 46 cardiovascular events in the controls compared with 36 in the low‐sodium diet groups (<a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>). The small number of events limited the ability of this earlier review to detect small to moderate reductions in the risk of cardiovascular events.   </p> <p>Given that the effect of interventions to reduce dietary salt on blood pressure is well established and health policy in the area of salt reduction has advanced, the primary focus of this review is to confirm whether reducing dietary salt through advice or substitution is associated with improvements in mortality and cardiovascular events. </p> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009217-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009217-sec-0044"></div> <p> <ol id="CD009217-list-0001"> <li> <p>To assess the long‐term effects of advice and salt substitution, aimed at reducing dietary salt, on mortality and cardiovascular morbidity. </p> </li> <li> <p>To investigate whether a reduction in blood pressure is an explanatory factor in the effect of such dietary interventions on mortality and cardiovascular outcomes. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009217-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009217-sec-0045"></div> <section id="CD009217-sec-0046"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009217-sec-0047"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs), individual or cluster level, with follow‐up of at least six months. </p> </section> <section id="CD009217-sec-0048"> <h4 class="title">Types of participants</h4> <p>Studies in adults (18 years or older), irrespective of gender or ethnicity. We excluded studies in patients with heart failure, children or pregnant women. </p> </section> <section id="CD009217-sec-0049"> <h4 class="title">Types of interventions</h4> <p>Reducing dietary salt intake, either by advice from health professionals or provision of low‐sodium salt substitution. The comparison group could include usual, control or placebo diet, or no intervention. </p> </section> <section id="CD009217-sec-0050"> <h4 class="title">Types of outcome measures</h4> <section id="CD009217-sec-0051"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009217-list-0002"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Cardiovascular mortality.</p> </li> <li> <p>Cardiovascular morbidity (including fatal and non‐fatal myocardial infarction, stroke, angina, heart failure, peripheral vascular events, sudden death, revascularisation (coronary artery bypass surgery or angioplasty with or without stenting) and cardiovascular‐related hospital admissions). </p> </li> </ol> </p> <p>We assessed primary outcomes at study end and also at the latest trial follow‐up, where participants had been followed observationally after the end of the original trial. </p> </section> <section id="CD009217-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p>In studies that reported the primary outcomes we also sought the following secondary outcomes: </p> <p> <ol id="CD009217-list-0003"> <li> <p>Changes in systolic and diastolic blood pressure.</p> </li> <li> <p>Urinary salt excretion (or other method of estimation of salt intake).</p> </li> <li> <p>Health‐related quality of life using a validated outcome measure (e.g. Short Form 36, <a href="./references#CD009217-bbs2-0055" title="McHorneyCA , Ware JrJE , RaczekAE . The MOS 36‐item Short‐Form Health Survey (SF‐36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care1993;31:247‐63. ">McHorney 1993</a>). </p> </li> </ol> </p> </section> </section> </section> <section id="CD009217-sec-0053"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009217-sec-0054"> <h4 class="title">Electronic searches</h4> <p>We updated the searches, initially run in 2008 (<a href="./appendices#CD009217-sec-0093">Appendix 1</a>), and re‐ran these on 1 May 2013 (<a href="./appendices#CD009217-sec-0099">Appendix 2</a>). We searched the following databases: </p> <p> <ul id="CD009217-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 4);</p> </li> <li> <p>MEDLINE (OVID, 1946 to April week 3 2013);</p> </li> <li> <p>EMBASE Classic + EMBASE (OVID, 1947 to 30 April 2013);</p> </li> <li> <p>CINAHL Plus with Full Text (EBSCO, to 1 April 2013);</p> </li> <li> <p>PsycINFO (OVID, 1806 to October 2008 ‐ not updated as resources were limited);</p> </li> <li> <p>Health Technology Assessment (HTA) on <i>The Cochrane Library</i> (2008, Issue 4 ‐ not updated as resources were limited); </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE) on <i>The Cochrane Library</i> (2008, Issue 4 ‐ not updated as resources were limited). </p> </li> </ul> </p> <p>Searches conducted in MEDLINE, EMBASE, CINAHL and PsycINFO included a controlled trials filter in 2008. We updated this in 2013 to the Cochrane sensitivity‐maximising RCT filter for MEDLINE and adaptations of it for EMBASE and CINAHL (<a href="./references#CD009217-bbs2-0050" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We limited the searches in MEDLINE, EMBASE and CINAHL by entry dates/weeks to identify only newly added records since the last search. We limited the CENTRAL search by publication dates. </p> <p>We applied no language restrictions.</p> </section> <section id="CD009217-sec-0055"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of all eligible trials and relevant systematic reviews for additional studies. </p> </section> </section> <section id="CD009217-sec-0056"> <h3 class="title" id="CD009217-sec-0056">Data collection and analysis</h3> <section id="CD009217-sec-0057"> <h4 class="title">Selection of studies</h4> <p>Two authors (KA and RST) independently screened the titles and abstracts of studies identified by the original search and discarded clearly irrelevant studies. In order to be selected, abstracts had to identify clearly the study design, an appropriate population and a relevant intervention/exposure, as described above. We obtained the full‐text reports of all potentially relevant studies and two authors (KA and RST) assessed these independently for eligibility, based on the defined inclusion criteria. We resolved any disagreement by discussion or where agreement could not be reached, by consultation with an independent third person (LH). For the update, two authors (AJA, FCT or NM) independently screened half the abstracts. A third author (NM) checked 10% of all studies. Two authors (AJA and FCT) checked full‐text articles of potentially relevant studies. A third author (NM) checked all excluded studies. </p> </section> <section id="CD009217-sec-0058"> <h4 class="title">Data extraction and management</h4> <p>We used standardised data extraction forms. We extracted relevant data regarding inclusion criteria (study design, participants, intervention/exposure and outcomes), risk of bias (see below) and outcome data. A single author (KA or RST) carried out data extraction and a second author (RST or KA) checked this. We resolved disagreements by discussion or, if necessary, with a third author (LH). We extracted outcomes at the latest follow‐up point within the trial, and also at the latest follow‐up after the trial where this was available, as we reasoned this would maximise the number of events reported. We contacted all included study authors to clarify any missing outcome data or issues of 'Risk of bias' assessment. For the update, two authors (AJA or FCT and SE) carried out data extraction independently. </p> </section> <section id="CD009217-sec-0059"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Factors considered included random sequence generation and allocation concealment, description of drop‐outs and withdrawals, blinding (participants, personnel and outcome assessment) and selective outcome reporting. In addition we sought evidence that the groups were balanced at baseline, that intention‐to‐treat analysis was undertaken and that the period over which the salt intervention lasted and follow‐up of outcome were equivalent. A single author (KA) assessed the risk of bias of the included studies and a second author (RST) checked this. We resolved disagreements by discussion or if necessary with a third author (LH). Two authors (AJA and FCT) independently checked risk of bias in the update. </p> </section> <section id="CD009217-sec-0060"> <h4 class="title">Data synthesis</h4> <p>We processed data as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009217-bbs2-0044" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). For mortality and cardiovascular events, we calculated the risk ratio and 95% confidence interval (CI) for each trial. For blood pressure and urinary sodium excretion, we calculated mean group differences and 95% CI using the mean difference. We explored heterogeneity amongst included studies qualitatively (by comparing the characteristics of included studies) and quantitatively (using the Chi² test of heterogeneity and the I² statistic). We combined results from included studies for each outcome to give an overall estimate of treatment effect at the latest point available within the randomised trial and, as a secondary analysis, at the latest point available (including where participants were followed up after the end of the randomisation period). We used a fixed‐effect meta‐analysis except where statistical heterogeneity was identified (Chi² P value ≤ 0.05 and I² value ≥ 50%), in which case we considered methodological and clinical reasons for heterogeneity and used a random‐effects model. </p> </section> <section id="CD009217-sec-0061"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to use stratified meta‐analysis to explore the differential effects that might occur as a result of: individual advice versus group advice, salt substitution versus advice and baseline risk of cardiovascular disease. We used meta‐regression to assess the effects of the level of salt reduction achieved, baseline blood pressure and change in blood pressure on mortality and cardiovascular event outcomes. </p> </section> <section id="CD009217-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analysis of the primary outcomes to determine whether cluster and individually randomised trial designs influenced the effects observed. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009217-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009217-sec-0063"></div> <section id="CD009217-sec-0064"> <h3 class="title">Description of studies</h3> <section id="CD009217-sec-0065"> <h4 class="title">Results of the search</h4> <p>The searches in 2013 retrieved 2439 references and 1861 remained after de‐duplication. We excluded 1737 references based on screening the title and abstract. We retrieved the remaining 124 references in full text, two of which met the inclusion criteria (two reports) (<a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>). We also identified three additional reports for previously included studies. </p> <p>The searches in 2008 identified a total of 2649 titles, of which we excluded 2605 on title and abstract. After examining the full texts of the remaining 44 papers, we included six trials (26 reports) (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). </p> <p>Five studies from an earlier Cochrane review, <a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>, met the inclusion criteria (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a> (18 months); <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). We excluded the other six included studies from <a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>, as they did not report mortality or cardiovascular events (<a href="./references#CD009217-bbs2-0022" title="AlliC , AvanziniF , BettelliG , BonatiM , ColomboF , CorsoR , et al. Feasibility of a long‐term low‐sodium diet in mild hypertension. Journal of Human Hypertension1992;6:281‐6. ">Alli 1992</a>; <a href="./references#CD009217-bbs2-0023" title="ArrollB , BeagleholeR . Salt restriction and physical activity in treated hypertensives. New Zealand Medical Journal1995;108:266‐8. ">Arroll 1995</a>; <a href="./references#CD009217-bbs2-0030" title="CostaFV , AmbrosioniE , MontebugnoliL , PaccaloniL , VasconiL , MagnaniB . Effects of low‐salt diet and of acute salt loading on blood pressure and intralymphatic sodium concentration in young subjects with borderline hypertension. Clinical Science1981;61(Suppl 7):21‐3S. ">Costa 1981</a>; <a href="./references#CD009217-bbs2-0059" title="MorganT , AndersonA . Sodium restriction can delay the return of hypertension in patients previously well‐controlled on drug therapy. Canadian Journal of Physiology and Pharmacology1987;65:1720‐5. ">Morgan 1987</a>; <a href="./references#CD009217-bbs2-0067" title="SilmanAJ , LockeC , MitchellP , HumphersonP . Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension. Lancet1983;1(8335):1179–82. ">Silman 1983</a>; <a href="./references#CD009217-bbs2-0071" title="ThalerBI , PaulinJM , PhelanEL , SimpsonFO . A pilot study to test the feasibility of salt restriction in a community. New Zealand Medical Journal1982;95:839‐42. ">Thaler 1982</a>). </p> <p>In total, we included eight trials (reported in 31 papers) and one ongoing study (<a href="./references#CD009217-bbs2-0016" title="AungMY , YuasaM , MoolphateS , NedsuwanS , YokokawaH , KitajimaT , et al. Reducing salt intake for prevention of cardiovascular disease in high‐risk patients by advanced health education intervention (RESIP‐CVD study), Northern Thailand: study protocol for a cluster randomised trial. Trials2012;13:158. ">Aung 2012</a>). </p> <p>We obtained responses to our requests for additional details from four of the included trial authors (<a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). </p> <p>The study selection process is summarised in the flow diagram shown in <a href="#CD009217-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009217-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="578Study flow diagram for review and update" data-id="CD009217-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>578Study flow diagram for review and update</p> </div> </div> </div> </section> <section id="CD009217-sec-0066"> <h4 class="title">Included studies</h4> <p>The eight included studies are described in the <a href="./references#CD009217-sec-0121" title="">Characteristics of included studies</a> table.  </p> <p>We included three trials in people with normotension (n = 3518) (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>), two in people with hypertension (n = 748) (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>), and three in a mixed population of people with normo‐ and hypertension (n = 3018) (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>). For the purposes of analysis, we included studies in mixed normo‐ and hypertensive individuals with the hypertensive studies. </p> <p>Post‐randomisation follow‐up varied from up to six to nine months (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>), to around three‐years (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>), and long‐term post‐trial end follow‐up of 10 to 15 years (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). </p> <p>The three normotensive trials were in healthy people (predominantly white (&gt; 75%), male (75%), median age 40) and were conducted in the USA. Entry criteria varied between trials, but included those with diastolic blood pressure from 78 mmHg to 89 mmHg, with a narrow range of means from 83 mmHg to 86 mmHg diastolic and 124 mmHg to 127 mmHg systolic. The number of participants included ranged from 392 to 2382. </p> <p>All three trials in normotensives (as well as <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>, below) aimed to reduce salt by comprehensive dietary and behaviour change programmes led by experienced personnel, including regular group counselling sessions over several months, with newsletters between sessions, self assessment, goal setting, food tasting and recipes. For example, the Hypertension Prevention Trial (HPT) ran 10 weekly group counselling sessions on food selection, food preparation and behaviour management skills, followed by semi‐monthly and then bi‐monthly meetings throughout the trial (with newsletters in the months where no meetings occurred) (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>). Sessions were run by nutritionists and behavioural scientists and individual counselling was provided, where participants missed sessions or had special needs. Techniques used in the sessions included group discussions, instructions for dietary record keeping, goal setting, individual diet analysis for each participant, cooking demonstrations, provision of recipe books and tasting of new foods. The intervention duration ranged from seven months (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>) to 36 months (<a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>). Control groups received no active intervention. Sodium excretion goals were set at less than 70 to 80 mmol/24 hours. Only two studies used salt substitution; one gradually increased the use of a potassium‐enriched salt substitute over several weeks, although this was done in kitchens by cooks without requiring participants to alter their behaviours (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>), and the other advised participants to use a low‐sodium salt substitute (<a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>). </p> <p>The five trials that included hypertensives included one trial in treated hypertensive participants (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>), two that included participants with untreated hypertension (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>), one study with a proportion of treated participants (<a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>) and one unspecified (<a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>). In the mixed studies, the per cent with hypertension ranged from 40% (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>) to 60% (<a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>). Studies were carried out in Australia, China, Hong Kong,Taiwan and the USA and ranged in size from 77 to 1981 participants. Between 15% and 100% of participants were male, with a median age of 60 years.Most studies did not report ethnicity. At study entry mean diastolic blood pressure ranged from 71 mmHg (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>, on treatment) to 97 mmHg (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>, untreated) and systolic blood pressure ranged from approximately 131 mmHg (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>, untreated; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>, on treatment) to 162 mmHg (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>, untreated).   </p> <p>Sodium goals varied from &lt; 80 mmol/day (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>) to 70 to 100 mmol/day and unspecified sodium intake (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). </p> </section> <section id="CD009217-sec-0067"> <h4 class="title">Excluded studies</h4> <p>Studies that were close to meeting but did not meet our inclusion criteria are listed in the <a href="./references#CD009217-sec-0122" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD009217-sec-0068"> <h3 class="title">Risk of bias in included studies</h3> <p>A number of studies failed to give sufficient detail to assess their potential risk of bias. </p> <p>Details of the generation and concealment of the random allocation sequence were particularly poorly reported (<a href="#CD009217-fig-0002">Figure 2</a>; <a href="#CD009217-fig-0003">Figure 3</a>). However, in all cases there was objective evidence of balance in the baseline characteristics of the intervention and control participants. </p> <div class="figure" id="CD009217-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009217-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009217-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009217-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>For blinding of outcome assessment we assumed there to be low risk of bias, as the primary outcomes of mortality and major cardiovascular disease morbidity are unlikely to be wrongly assessed based on participant allocation. </p> <p>While studies reported loss to follow‐up and reasons for loss to follow‐up, only a few undertook a sensitivity or imputation analysis to assess the impact of these losses, followed up participants for event outcomes and described reasons for loss to follow‐up for other outcomes. In the Trial of Nonpharmacologic Intervention in the Elderly (TONE) trial, the authors stated that data were collected via psychological questionnaires at randomisation and a number of the follow‐up visits (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). However, none of these data were found in the trial reports. Although often not stated, all studies appeared to undertake an intention‐to‐treat analysis in that groups were analysed according to initial random allocation. </p> <p>All studies assessed compliance with the salt reduction intervention using diet diaries or monitoring of use. However, in the longer‐term post‐trial end follow‐up of the TOHP I (11.5 years), TOHP II (eight years) and TONE (12.7 years) trials, such compliance data were not reported beyond the official end of the study (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). Therefore it was unclear whether intervention groups were encouraged to continue their low‐salt diets long‐term, or returned to their pre‐trial diet. Similarly, in the control groups it is not clear whether they were left to continue with their usual diet or advised to reduce their salt at the end of the trial. </p> </section> <section id="CD009217-sec-0069"> <h3 class="title" id="CD009217-sec-0069">Effects of interventions</h3> <p>Given the heterogeneity of populations and the likelihood that normotensives and hypertensives would differ in their adherence to dietary interventions, the results are presented and pooled separately for studies of people with normotension and hypertension. We pooled outcomes at end of trial and at the longest follow‐up point unless otherwise indicated. </p> <section id="CD009217-sec-0070"> <h4 class="title">Primary outcomes</h4> <section id="CD009217-sec-0071"> <h5 class="title">All‐cause mortality</h5> <p>All‐cause mortality was reported at the end of the trial in seven of the included studies (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>). Trials were homogeneous and therefore we pooled them using a fixed‐effect model. There was no strong evidence of a reduction in the number of deaths in the reduced salt group relative to controls for the normotensive (fixed‐effect risk ratio (RR) 0.67, 95% confidence interval (CI) 0.40 to 1.12, 60 deaths in total, I² = 0%) or hypertensive populations (fixed‐effect RR 1.00, 95% CI 0.86 to 1.15, 565 deaths in total, I² = 0%) (<a href="./references#CD009217-fig-0004" title="">Analysis 1.1</a>). </p> <p>A longer observational follow‐up following the end of the randomised trial period was reported for the Trials of Hypertension Prevention (TOHP) I (11.5 years) and TOHP II (eight years) trials (<a href="./references#CD009217-bbs2-0028" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. ">Cook 2007</a>). We were also able to obtain longer observational unpublished data from the authors from the Trial of Nonpharmacologic Intervention in the Elderly (TONE) study (12.7 years) (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). Trials remained homogeneous. At longest follow‐up, there was still no evidence of a reduction in the number of deaths in the reduced salt group relative to controls, for the normotensive (fixed‐effect RR 0.90, 95% CI 0.58 to 1.40, 79 deaths in total, I² = 0%) or hypertensive populations (fixed‐effect RR 0.99, 95% CI 0.87 to 1.14, 674 deaths; I² = 0%) (<a href="./references#CD009217-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD009217-sec-0072"> <h5 class="title">Cardiovascular mortality</h5> <p>Cardiovascular mortality was reported in three studies including hypertensive patients. <a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a> reported a lower proportion of cardiovascular deaths in the intervention group than in the control group (27 versus 66) and contributed 90% weight to this analysis. Importantly, dietary salt was substituted gradually with a potassium‐rich, low‐salt product in the kitchens used by residents in retirement homes. <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a> reported only one cardiovascular death in the intervention group and none in the control group, but in a subsequent publication two cardiovascular deaths were reported in each of the intervention and control groups (<a href="./references#CD009217-bbs2-0058" title="MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1980</a>). There was no difference in the other study (<a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>). The pooled risk ratio shows weak, inconclusive evidence of benefit (fixed‐effect RR 0.67, 95% CI 0.45 to 1.01, 106 cardiovascular deaths, I² = 0%) (<a href="./references#CD009217-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD009217-sec-0073"> <h5 class="title">Cardiovascular morbidity</h5> <p>We assessed cardiovascular events (both fatal and non‐fatal) at end of trial. The definition of non‐fatal cardiovascular events varied from trial to trial, although it broadly consisted of a composite of myocardial infarction, stroke, coronary artery bypass and percutaneous transluminal coronary angioplasty. Data at end of trial were only available in trials of hypertensives (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>), and demonstrated weak evidence of a reduction in events (fixed‐effect RR 0.76, 95% CI 0.57 to 1.01, 192 events, I² = 0%) (<a href="./references#CD009217-fig-0007" title="">Analysis 1.4</a>). Cardiovascular events at longest follow‐up were also examined to maximise the number of events available for analysis and gain data for normotensives. Data were available from six trials (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>). Following long‐term observational follow‐up, TOHP I and II reported no strong evidence of risk reduction, with heterogeneity of effect between the two trials in normotensive participants (random‐effects RR 0.84, 95% CI 0.64 to 1.10). We found weak evidence of benefit in hypertensive individuals (fixed‐effect RR 0.77, 95% CI 0.58 to 1.02; I<sup>2</sup> = 0%). Pooling across normotensive and hypertensive trials gives modest evidence of benefit for cardiovascular events at longest follow‐up (random‐effects RR 0.81, 95% CI 0.66 to 0.98; I<sup>2</sup> = 0%) (<a href="./references#CD009217-fig-0008" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD009217-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD009217-sec-0075"> <h5 class="title">Changes in systolic and diastolic blood pressure</h5> <p>End of trial blood pressure was reported by five studies (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a> reported end of trial blood pressure but did not provide standard deviations (SD), so we imputed the median SD of the other studies to include the findings in the pooled analysis using the methodology outlined in section 7.7.3.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009217-bbs2-0044" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a> did not report end of trial blood pressure but stated that there was no difference between intervention and control groups. For systolic blood pressure there was evidence of substantial statistical heterogeneity in the normotensive groups, but not the hypertensive studies. Systolic blood pressure was reduced in all intervention arms: normotensives (random‐effects mean difference (MD) ‐1.15 mmHg, 95% CI ‐2.32 to 0.02, I² = 64%) and hypertensives (random‐effects MD ‐4.14 mmHg, 95% CI ‐5.84 to ‐2.43, I² = 0%). Combining normotensives and hypertensives resulted in substantial heterogeneity (I² = 74%) and moderate evidence of benefit (random‐effects MD ‐1.79 mmHg, 95% CI ‐3.23 to ‐0.36). Diastolic blood pressure was also reduced in normotensives (random‐effects MD ‐0.80 mmHg, 95% CI ‐1.37 to ‐0.23, I² = 0%), but not in hypertensives (random‐effects MD ‐3.74 mmHg, 95% CI ‐8.41 to 0.93, I² = 67%). In this analysis there was no heterogeneity in normotensives, but substantial heterogeneity in hypertensives. Pooled analysis of normotensives and hypertensives showed moderate evidence of an effect (random‐effects MD ‐1.17 mmHg, 95% CI ‐2.08 to ‐0.26) (<a href="./references#CD009217-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD009217-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD009217-sec-0076"> <h5 class="title">Urinary salt excretion (or other method of estimation of salt intake)</h5> <p>Changes in urinary sodium excretion at the end of trial were reported by six studies (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>; <a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). There was substantial evidence of statistical heterogeneity, which may reflect different approaches to the assessment of 24‐hour urinary sodium excretion. In the study by Morgan, results were only reported as samples and therefore comprised repeated observations for a number of patients (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>). As for blood pressure, in a number of studies the last urinary sodium excretion value available was at a time point much preceding the timing of the reported mortality or cardiovascular events (blood pressure follow‐up time: six months (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>); 30 months (<a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>); 18 months (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>); 36 months (<a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>)). Urinary 24‐hour sodium excretion was reduced by a similar amount across the study subgroups: normotensives (random‐effects MD ‐34.19 mmol/24 hours, 95% CI ‐49.61 to ‐18.78, I² = 76%); hypertensives (random‐effects MD ‐20.48 mmol/24 hours, 95% CI ‐53.68 to 12.73, I² = 98%) and pooled analysis (random‐effects MD ‐27.21 mmol/24 hours, 95% CI ‐49.85 to ‐4.57, I² = 97%) (<a href="./references#CD009217-fig-0011" title="">Analysis 1.8</a>). </p> </section> <section id="CD009217-sec-0077"> <h5 class="title">Health‐related quality of life</h5> <p>One study in normotensives reported that significant improvements on the Psychological General Well‐Being scale were observed at six and 18 months, but no data were presented (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>). </p> </section> </section> <section id="CD009217-sec-0078"> <h4 class="title">Subgroup analyses and investigation of heterogeneity</h4> <p>In order to take to take account of the heterogeneity in populations and cardiovascular baseline risk, we stratified meta‐analyses according to whether studies were undertaken in normotensive or hypertensive populations. As one of the studies involved a kitchen salt substitution rather than requiring participants to change their behaviours, we conducted a subgroup analysis excluding this trial (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). This resulted in reductions in the pooled effects observed (cardiovascular mortality at end of trial: RR 0.87, 95% CI 0.30 to 2.55; cardiovascular events at end of trial: RR 0.86, 95% CI 0.57 to 1.30; cardiovascular events at longest follow‐up: RR 0.81, 95% CI 0.63 to 1.03). As this trial did not measure blood pressure or urinary sodium excretion we were not able to explore its effects on these outcomes. </p> </section> <section id="CD009217-sec-0079"> <h4 class="title">Small study bias</h4> <p>Given the small number of included studies it was not possible to assess small study bias either statistically or using a funnel plot. </p> </section> <section id="CD009217-sec-0080"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analysis for the primary outcomes by removing the <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a> and <a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a> studies as they were cluster‐randomised trials. Both studies were carried out in hypertensives, so results for normotensives remained unchanged. <a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a> was the largest study conducted in hypertensives, so the overall result of removing it was to reduce the sample size and considerably decrease the precision of the estimate. For the primary outcome all‐cause mortality at end of trial, the two removed trials had accounted for 86.9% of the weight, thus the sensitivity analysis increased the relative weight of the <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a> and <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a> trials. As a result, even though the pooled estimate for hypertensives was higher in sensitivity analysis, the pooled estimate was lower than the main analysis but with less precision (RR 0.73, 95% CI 0.45 to 1.17, 69 events, 4193 participants) (<a href="./references#CD009217-fig-0012" title="">Analysis 2.1</a>). For cardiovascular mortality, removing the cluster‐randomised trials decreased the effect estimate and decreased the precision (RR 0.87, 95% CI 0.29 to 2.64, 13 events, 675 participants) (<a href="./references#CD009217-fig-0013" title="">Analysis 2.2</a>). For cardiovascular disease events at end of trial, removing <a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a> resulted in <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a> increasing in weight to 84.5% of the estimate, and resulted in salt reduction showing less evidence of an effect (RR 0.86, 95% CI 0.57 to 1.30, 101 events, 1416 participants) (<a href="./references#CD009217-fig-0014" title="">Analysis 2.3</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009217-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009217-sec-0081"></div> <section id="CD009217-sec-0082"> <h3 class="title" id="CD009217-sec-0082">Summary of main results</h3> <p>This Cochrane review identified eight randomised controlled trials that assessed the long‐term (more than six months) effects of interventions aimed at reducing dietary salt on mortality and cardiovascular morbidity. Three trials were in normotensives (<a href="./references#CD009217-bbs2-0003" title="BorhaniNO , TonasciaJ , SchlundtDG , PrineasRJ , JefferysJL . Recruitment in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):30‐9S. BrownKM , ObermanA , VanNattaML , ForsterJL . Baseline characteristics in the hypertension prevention trial. Controlled Clinical Trials1989;10(Suppl 3):40‐64S. ForsterJL , JefferyRW , VanNattaM , PirieP . Hypertension prevention trial: do 24‐h food records capture usual eating behavior in a dietary study?. American Journal of Clinical Nutrition1990;51:253‐7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three‐year effects of dietary changes on blood pressure. Archives of Internal Medicine1990;150:153‐62. JefferyRW , FrenchSA , SchmidTL . Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial. Health Psychology1990;9:315‐29. JefferyRW , TonasciaS , BjornsonBW , SchlundtDG , Sugars C for the Hypertension Prevention Trial Research Group. Treatment in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):65‐83S. MeinertCL , BorhaniNO , LangfordHG . Design, methods, and rationale in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):1‐29S. PrudhommeGJ , CannerPL , CutlerJA . Quality assurance and monitoring in the Hypertension Prevention Trial. Controlled Clinical Trials1989;10(Suppl 3):84‐94S. SchmidTL , JefferyRW , OnstadL , CorriganSA . Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension. Addictive Behaviors1991;16:151‐60. ShahM , JefferyRW , LaingB , SavreSG , VanNM , StricklandD . Hypertension Prevention Trial (HPT): food pattern changes resulting from intervention on sodium, potassium, and energy intake. Journal of the American Dietetic Association1990;90:69‐76. ">HPT 1990</a>; <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a>, n = 3518 participants), two in hypertensives (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>, n = 748 participants) and three in mixed populations of normo‐ and hypertensives (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>; <a href="./references#CD009217-bbs2-0002" title="The China Salt Substitute Study Collaborative Group. Salt substitution: a low‐cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. Journal of Hypertension2007;25:2011‐8. ">CSSS 2007</a>; <a href="./references#CD009217-bbs2-0004" title="KwokTCY , LamLCW , SeaMMM , GogginsW , WooJ . A randomized controlled trial of dietetic interventions to prevent cognitive decline in old age hostel residents. European Journal of Clinical Nutrition2012;66:1135‐40. ">Kwok 2012</a>, n = 3018 participants). </p> <p>We found no strong evidence that dietary advice or substitution to reduce salt intake reduced all‐cause mortality in normotensives (end of trial risk ratio (RR) 0.67, 95% confidence interval (CI) 0.40 to 1.12, 60 deaths, 3518 participants; longest follow‐up RR 0.90, 95% CI 0.58 to 1.40, 79 deaths, 3518 participants), or in hypertensives (end of trial RR 1.00, 95% CI 0.86 to 1.15, 565 deaths, 3085 participants; longest follow‐up RR 0.99, 95% CI 0.87 to 1.14, 674 deaths, 3680 participants).  </p> <p>There was weak evidence that cardiovascular mortality and cardiovascular events were reduced among hypertensives (cardiovascular mortality: end of trial RR 0.67, 95% CI 0.45 to 1.01, 106 deaths, 2656 participants; cardiovascular events: end of trial RR 0.76, 95% CI 0.57 to 1.01, 194 deaths, 3397 participants), however these results were strongly driven by the <a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a> study, which accounted for 88% of the weight in the cardiovascular mortality analysis and 49% of the weight in cardiovascular events analysis. There was no strong evidence that cardiovascular events (fatal and non‐fatal combined) were reduced in people with normal blood pressure (longest follow‐up RR 0.71, 95% CI 0.42 to 1.20, 200 events, 2505 participants), but in hypertensives there was weak evidence of benefit (longest follow‐up RR 0.77, 95% CI 0.57 to 1.02, 192 events, 3407 participants). Maximising the available data by pooling across normotensive and hypertensive groups and using the data collected by some trials after the trial end date gave a 'significant' result (RR 0.77, 95% CI 0.63 to 0.95, P value &lt; 0.01). This result was driven by the trial of residents in institutions where salt reduction was achieved by changes in salt used in the institution kitchens (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). Excluding this trial from the analysis gave an overall effect of RR 0.81 (95% CI 0.63 to 1.03) for cardiovascular events at longest follow‐up. Both <a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a> and <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a> were carried out in overweight individuals (average body mass index (BMI) in TOHP I 27.1, mean BMI in TOHP II 30.9 in both intervention and control), so the effects of dietary advice to reduce salt found in this trial may not be applicable to non‐overweight people. </p> <p>Although no data were published on participant's health‐related quality of life, in one trial among normotensives it was reported that there were significant improvements in quality of life in the intervention group (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>). </p> <p>The interventions reduced urinary sodium excretion and indicated that participants continued to comply with sodium restriction in the long term, at least to some degree, although, as noted in a previous Cochrane review, the degree of sodium restriction is likely to attenuate over time (<a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>). End of trial systolic and diastolic blood pressure were reduced by an average of 1 mmHg in normotensives and by an average of 2 to 4 mmHg in hypertensives. </p> <p>Sustained long‐term reductions of diastolic blood pressure of 1 mmHg and 4 mmHg would be predicted to reduce cardiovascular disease mortality by 5% and 20% respectively (<a href="./references#CD009217-bbs2-0054" title="MacMahonS , PetoR , CutlerJ , CollinsR , SorlieP , NeatonJ , et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet1990;335:765‐74. ">MacMahon 1990</a>). Our point estimates among hypertensives are consistent with effects of this size, but have wide confidence intervals owing to the relatively small number of events. Among normotensives our point estimate of benefit is rather larger (about a 30% risk reduction in cardiovascular events), which probably reflects the use of the long‐term follow‐up data from the TOHP I and II trials These provide the only relevant data but they may be biased by losses to follow‐up for non‐fatal events and no data on blood pressure or urinary sodium excretion were available to assess the extent to which participants had maintained trial values (<a href="./references#CD009217-bbs2-0028" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. ">Cook 2007</a>). The systolic blood pressure reduction in the TOHP I and II trials was between 1 mmHg and 2 mmHg, which would not be expected to produce such a large reduction in cardiovascular events. </p> <p>Findings from sensitivity analysis excluding cluster‐randomised trials are less precise, but overall are consistent with the main analysis. </p> </section> <section id="CD009217-sec-0083"> <h3 class="title" id="CD009217-sec-0083">Overall completeness and applicability of evidence</h3> <p>A previous Cochrane review was limited by the lack of reported events (17 deaths, 93 cardiovascular events) (<a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>). In this review, because of longer observational follow‐up (up to 10 to 15 years) of three of the trials included in the previous Cochrane review (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>; <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a> (eight years); <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a> (12.7 years)) and inclusion of one more recent randomised controlled trial (RCT) (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>), we have gathered more evidence on mortality and cardiovascular outcomes (approximately 7200 participants, 753 deaths and 392 cardiovascular events). Nevertheless, the total amount of evidence on events remains limited. The question arises of how much more evidence would be required to give a conclusive answer on the benefits of advice to reduce salt intake. Assuming a 15% risk of suffering a cardiovascular event over 10 years (consistent with mild hypertension at age 60 in a man), a trial with 80% power and a significance level of 5% would require randomisation of about 25,000 people to intervention and control arms with follow‐up for 10 years to detect a 10% reduction in cardiovascular events. However, targeting a 20% reduction in cardiovascular events ‐ similar to the effects of antihypertensives or statins in primary prevention of cardiovascular disease ‐ and a shorter follow‐up of five years would require a more feasible trial of 12,000 participants. The randomised evidence to support antihypertensive drug treatment comprises over 120,000 participants followed for about five years and provides conclusive evidence of benefit. Despite over a decade of advocacy for salt reduction as a major public health strategy, it is remarkable that an evidence base a 10th of the size of the equivalent pharmacological database has been produced. Doing better than this is considered impracticable because of logistic, financial and ethical issues (<a href="./references#CD009217-bbs2-0040" title="HeFJ , MacGregorGA . Salt reduction lowers cardiovascular risk: meta‐analysis of outcome trials. Lancet2011;378:380‐2. ">He 2011</a>). </p> <p>More recently, the US Institute of Medicine, in its review of the evidence on salt and health, has recommended further trials to examine the effects of a range of sodium levels on the risk of cardiovascular events, stroke and mortality among patients in controlled environments, where randomised trials may be more feasible, and in natural experiments (<a href="./references#CD009217-bbs2-0046" title="IOM (Institute of Medicine). Sodium Intake in Populations: Assessment of Evidence. Washington DC: The National Academies Press, 2013. ">Institute of Medicine 2013</a>). In response to this the TOHP I and II trial investigators reported long‐term observational findings from the control groups of these trials, which did not show a J‐shaped association but indicated that urinary sodium excretion is linearly associated with cardiovascular events, although only 10% of the participants had urinary sodium excretions of below 2300 mg/24 hours (<a href="./references#CD009217-bbs2-0029" title="CookNR , AppelLJ , WheltonPK . Lower levels of sodium intake and reduced cardiovascular risk. Circulation2014;129(9):981‐9. [DOI: 10.1161/CIRCULATIONAHA.113.006032] ">Cook 2014</a>), a little higher than the level of 2000 mg/24 hours recommended by the World Health Organization (<a href="./references#CD009217-bbs2-0076" title="World Health Organization. Guideline: Sodium intake for adults and children. Geneva: WHO, 2012. ">WHO 2012</a>). In contrast, an observational cohort analysis was unable to demonstrate a clear linear relationship between urinary sodium excretion and coronary heart disease events, although a weak interaction between urinary sodium excretion and plasma N‐terminal pro‐B‐type natriuretic peptide on coronary heart disease events was reported (<a href="./references#CD009217-bbs2-0047" title="JoostenMM , GansevoortRT , MukamalKJ , Lambers HeerspinkHJ , GeleijnseM , FeskensEJM , et al for the PREVEND Study Group. Sodium excretion and risk of developing coronary heart disease. Circulation2014;129(10):1121‐8. [DOI: 10.1161/CIRCULATIONAHA.113.004290] ">Joosten 2014</a>). Reviewing these new studies, Whelton stated that "... the potential for reverse causality, bias in assessment of sodium intake, absent or insufficient adjustment for confounding variables, and random error" all contribute to inconsistent findings (<a href="./references#CD009217-bbs2-0075" title="WheltonPK . Sodium, blood pressure and cardiovascular disease: a compelling scientific case for improving the health of the public. Circulation2014;129(10):1085‐7. [DOI: 10.1161/CIRCULATIONAHA.114.008138] ">Whelton 2014</a>). </p> </section> <section id="CD009217-sec-0084"> <h3 class="title" id="CD009217-sec-0084">Quality of the evidence</h3> <p>Although all included studies were RCTs, only two of the eight included studies provided sufficient detail to be judged as having adequate random sequence generation, allocation concealment and outcome blinding. One cluster‐randomised trial was analysed as if it was individually randomised (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). Nevertheless, all trials provided evidence of baseline balance. Although lack of blinding is unlikely to alter outcome assessment when outcomes include mortality and cardiovascular events, failure to blind participants may have led to a positive change in the lifestyle and dietary behaviours of control participants, leading to a reduction in the difference between groups. </p> <p>Most trials appeared to be free from dietary changes in the intervention and control groups, apart from dietary sodium. The one major exception was the trial by Chang where sodium was replaced by a high‐potassium substitute (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). Potassium has beneficial effects on blood pressure but may have adverse effects in individuals with renal disease (<a href="./references#CD009217-bbs2-0026" title="CappuccioFP . Sodium, potassium, calcium and magnesium and cardiovascular risk. Journal of Cardiovascular Risk2000;7:1‐3. ">Cappuccio 2000</a>). Two studies in hypertensives allowed changes in antihypertensive medication during the period of the trial (<a href="./references#CD009217-bbs2-0005" title="MorganT , AdamW , GilliesA , WilsonM , MorganG , CarneyS . Hypertension treated by salt restriction. Lancet1978;1(8058):227‐30. MorganTO , AdamsWR , HiodgsonM , GiverdRW . Failure to improve prognosis in elderly males with hypertension. Medical Journal Australia1980;2:27‐31. ">Morgan 1978</a>; <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a>). In both trials, lower levels of hypertensive medication in the intervention group compared to control may have reduced the blood pressure‐lowering effect of reduced dietary sodium and therefore offset mortality and cardiovascular morbidity benefits. </p> </section> <section id="CD009217-sec-0085"> <h3 class="title" id="CD009217-sec-0085">Potential biases in the review process</h3> <p>We searched comprehensively for randomised controlled trials of dietary sodium reduction, with a duration of six months or more and which reported mortality or cardiovascular events. We attempted to contact all authors of included studies to verify events. Nevertheless, we were unable to report all relevant outcomes for all trials. The small number of included studies prevented us from being able to assess the presence of small study or publication bias. </p> <p>By incorporating data from the longest follow‐up point, we sought to maximise the number of deaths and cardiovascular events that might be affected by alterations in dietary salt. However, in doing so we may have introduced a source of bias as not all trials conducted long‐term follow‐up. For three large studies (<a href="./references#CD009217-bbs2-0006" title="CookNR , CutlerJA , ObarzanekE , BuringJE , RexrodeKM , KumanyikaSK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow‐up of the trials of hypertension prevention (TOHP). BMJ2007;334:885‐8. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. JAMA1992;267:1213‐20. ">TOHP I 1992</a>, <a href="./references#CD009217-bbs2-0007" title="AppelLJ , HebertPR , CohenJD , ObarzanekE , YamamotoM , BuringJ , et al. Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Annals of Epidemiology1995;5:149‐55. HebertPR , BoltRJ , BorhaniNO , CookNR , CohenJD , CutlerJA , et al. Design of a multicenter trial to evaluate long‐term life‐style intervention in adults with high‐normal blood pressure levels. Trials of Hypertension Prevention (Phase II). Annals of Epidemiology1995;5:130‐9. HollisJF , SatterfieldS , SmithF , FouadM , AllenderPS , BorhaniN , et al. Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Annals of Epidemiology1995;5:140‐8. HuntSC , CookNR , ObermanA , CutlerJA , HennekensCH , AllenderPS , et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of Hypertension Prevention Phase II. Hypertension1998;32:393‐401. Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure. The Trials of Hypertension Prevention, phase II. Archives of Internal Medicine1997;157:657‐67. LasserVI , RaczynskiJM , StevensVJ , Mattfeldt‐BemanM , KumanyikaS , EvansM , et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Annals of Epidemiology1995;5:156‐64. ">TOHP II 1997</a> (eight years), <a href="./references#CD009217-bbs2-0008" title="AppelLJ , EspelandM , WheltonPK , DolecekT , KumanyikaS , ApplegateWB , et al. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. Annals of Epidemiology1995;5:119‐29. AppelLJ , EspelandMA , EasterL , WilsonAC , FolmarS , LacyCR . Effects of reduced sodium intake on hypertension control in older individuals. Results from the Trial of Nonpharmacological Interventions in the Elderly (TONE). Archives of Internal Medicine2001;161:685‐93. BahnsonJL , WheltonPK , AppelLJ , EspelandMA , WoffordJL , RosenR , et al. Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE). Disease Management and Clinical Outcomes1997;1:61‐8. EspelandMA , WheltonPK , KostisJB , BahnsonJL , EttingerWH , CutlerJA , et al. Predictors and mediators of successful long‐term withdrawal from antihypertensive medications. Archives of Family Medicine1999;8:228‐36. KostisJB , EspelandMA , AppelLJ , JohnsonKC , PierceJ , JamesL . Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?. American Journal of Cardiology1998;82:1501‐8. SheaMK , NicklasBJ , HoustonDK , MillerME , DavisCC , KitzmanDW , et al. The effect of intentional weight loss on all‐cause mortality in older adults: results of a randomized controlled weight‐loss trial. American Journal of Clinical Nutrituion2011;94:839‐46. WheltonPK , AppelLJ , EspelandMA , ApplegateWB , EttingerWHJr , KostisJB , et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA1998;279:839‐46. WheltonPK , BahnsonJ , AppelLJ , CharlestonJ , CosgroveN , EspelandMA , et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). Journal of the American Geriatric Society1997;45:185‐93. ">TONE 1998</a> (12.7 years)), the longest follow‐up was considerably beyond the official end of the trial and therefore can no longer be assumed to represent a randomised comparison. It was unclear if the intervention groups continued their low‐salt diets and whether control groups were left to continue with dietary advice or advised to reduce their salt. For this reason we consider the trial end findings to be a more robust, albeit less precise, source of evidence. </p> <p>In common with previous systematic reviews of dietary interventions, we observed marked heterogeneity across studies in terms of their population, sample size and follow‐up. Whilst we stratified meta‐analysis by differing sub‐populations (normotensives and hypertensives) and pooled studies using weighting based on sample size, we did not account for the duration of follow‐up. A previous Cochrane review suggests that over time the sodium reduction achieved is greatly reduced, as is the effect on blood pressure and therefore the effect on events is potentially diminished (<a href="./references#CD009217-bbs2-0045" title="HooperL , BartlettC , Davey SmithG , EbrahimS . Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD003656.pub2] ">Hooper 2004</a>). In a systematic review of trials of dietary salt reduction, sodium excretion was about half that in the two trials of over one‐year duration compared with the other trials with a median duration of four to five weeks (<a href="./references#CD009217-bbs2-0041" title="HeF , LiJ , MacGregorG A . Effect of longer‐term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews2013, Issue 4. [DOI: 10.1002/14651858.CD004937.pub2] ">He 2013a</a>; <a href="./references#CD009217-bbs2-0042" title="HeFJ , LiJ , MacGregorGA . Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta‐analysis of randomized trals. BMJ2013;346:f1325. ">He 2013b</a>), indicating that long‐term blood pressure reductions would be smaller with commensurate reductions in clinical benefit. </p> </section> <section id="CD009217-sec-0086"> <h3 class="title" id="CD009217-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p>Our finding of a lack of strong evidence of an effect of dietary sodium reduction advice on mortality and cardiovascular events in our 2011 Cochrane review was strongly contested on the grounds that we failed to consider the totality of the epidemiological, animal and short‐duration trials of blood pressure reduction, and that if we had pooled across people with and without hypertension our findings would have achieved statistical significance (<a href="./references#CD009217-bbs2-0040" title="HeFJ , MacGregorGA . Salt reduction lowers cardiovascular risk: meta‐analysis of outcome trials. Lancet2011;378:380‐2. ">He 2011</a>). The effects of dietary salt advice are greater in people with hypertension (possibly because of greater adherence) and underlying risks of cardiovascular disease are higher, which was our rationale for providing separate analyses. Indeed, the 'significant' effect that He and MacGregor achieved becomes 'non‐significant' depending on whether the odds ratio (0.78, 95% CI 0.61 to 0.99, P value =0.045) or rate ratio (0.88, 95% CI 0.77 to 1.00, P value = 0.054) is estimated, indicating the limitations of the available evidence and the problem of basing decisions on arbitrary thresholds of statistical significance (<a href="./references#CD009217-bbs2-0070" title="TaylorR , HooperL , EbrahimS . Dietary salt and cardiovascular disease. Lancet2011;378:1993. ">Taylor 2011</a>). Another Cochrane review examining the physiological effects of dietary salt reduction in a 167 trials found a 1% decrease in blood pressure in normotensives, a 3.5% decrease in hypertensives, a significant increase in plasma renin, plasma aldosterone, plasma adrenaline and plasma noradrenaline, a 2.5% increase in cholesterol and a 7% increase in triglyceride. The authors concluded, "There were increases in some hormones and lipids which could be harmful if persistent over time. However, the studies were not designed to measure long‐term health effects. Therefore we do not know if low‐salt diets improve or worsen health outcomes." (<a href="./references#CD009217-bbs2-0036" title="GraudalNA , Hubeck‐GraudalT , JurgensG . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD004022.pub3] ">Graudal 2011</a>). In a further Cochrane review, restricted to 34 trials of at least four weeks duration, there was no strong evidence of these hormonal and lipid effects, suggesting that they may not be long‐term problems (<a href="./references#CD009217-bbs2-0041" title="HeF , LiJ , MacGregorG A . Effect of longer‐term modest salt reduction on blood pressure. Cochrane Database of Systematic Reviews2013, Issue 4. [DOI: 10.1002/14651858.CD004937.pub2] ">He 2013a</a>; <a href="./references#CD009217-bbs2-0042" title="HeFJ , LiJ , MacGregorGA . Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta‐analysis of randomized trals. BMJ2013;346:f1325. ">He 2013b</a>). </p> <p>In light of the limited randomised evidence, non‐randomised observational evidence has been reviewed and meta‐analysed. In a review of prospective <i>observational</i> studies that examined the relationship between dietary sodium and cardiovascular events (<a href="./references#CD009217-bbs2-0069" title="StrazzulloP , D'EliaL , KandalaNB , CappuccioFP . Salt intake, stroke, and cardiovascular disease: meta‐analysis of prospective studies. BMJ2009;339:b4567. ">Strarzzullo 2009</a>), 13 cohort studies (177,025 participants) with follow‐up of 3 to 17 years were included. Higher salt intake was associated with a greater risk of stroke (pooled relative risk 1.23, 95% CI 1.06 to 1.43, 5161 events) and cardiovascular events (pooled relative risk 1.14, 95% CI 0.99 to 1.32, 5346 events). Total and cardiovascular mortality were not reported. A more recent update of this review reported inconclusive findings for all‐cause mortality and cardiovascular events, but did report an increased risk of coronary mortality (pooled relative risk 1.32, 95% CI 1.13 to 1.53) and stroke events (pooled relative risk 1.24, 95% CI 1.08 to 1.43) in those with high salt intakes (<a href="./references#CD009217-bbs2-0017" title="AburtoNJ , ZiolkovskaA , HooperL , ElliottP , CappuccioF , MeerpholJJ . Effect of lower sodium intake on health: systematic review and meta‐analyses. BMJ2013;346:f1326. ">Aburto 2013</a>). The inherent limitation of both of these reviews is the observational nature of the evidence on clinical outcomes, i.e. the studies describe the life course of persons who follow a self selected diet, unlike in randomised trials where allocation is at random and not self selected. People who choose a lower‐salt diet are likely also to eat a diet of fresh foods, lower in fats and refined carbohydrate, take more exercise and be less likely to smoke, so that their lower levels of deaths and disease may not relate to salt intake at all. </p> <p>Dietary advice appears to be only modestly effective at reducing salt intake and consequently has only small effects on blood pressure, particularly in the general population. Alternative means of reducing dietary salt intake include salt substitution, which may be relatively easy to implement in institutional and workplace kitchens as indicated in the one trial of an institutional kitchen intervention in this review (<a href="./references#CD009217-bbs2-0001" title="ChangHY , HuYW , YueCS , WenYW , YehWT , HsuLS , et al. Effect of potassium‐enriched salt on cardiovascular mortality and medical expenses of elderly men. American Journal of Clinical Nutrition2006;83:1289‐96. ">Chang 2006</a>). Experience in the United Kingdom and elsewhere has demonstrated that voluntary regulation, with the threat of government legislation, by the food industry has resulted in reductions in dietary sodium intake, although the effects have been small (a reduction from 9.5 g/day to 8.6 g/day but remaining a long way from a target of 6 g/day (<a href="./references#CD009217-bbs2-0025" title="CappuccioF , CapewellS , LincolnP , McPhersonK . Policy options to reduce population salt intake. BMJ2011;343:d4995. ">Cappuccio 2011</a>; <a href="./references#CD009217-bbs2-0057" title="MillettC , LavertyAA , StylianouN , Bibbins‐DomingoK , PapeUJ . Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study. PloS One2012;7:e29836. ">Millett 2012</a>). Evidence from other countries suggests that regulatory approaches are needed (<a href="./references#CD009217-bbs2-0072" title="WebsterJL , DunfordEK , HawkesC , NealBC . Salt reduction initiatives around the world. Journal of Hypertension2011;29:1043‐50. ">Webster 2011</a>), and are cost‐saving compared with dietary advice, which is not cost‐effective in Australian scenarios (<a href="./references#CD009217-bbs2-0027" title="CobiacLJ , VosT , VeermanJL . Cost‐effectiveness of interventions to reduce dietary salt intake. Heart2010;96:1920‐5. ">Cobiac 2010</a>). In a recent review of the evidence, Whelton considered that "... a gradual decrease in the addition of Na to food products represents the easiest "lifestyle" change for the general population and the intervention option with the greatest potential for success" (<a href="./references#CD009217-bbs2-0075" title="WheltonPK . Sodium, blood pressure and cardiovascular disease: a compelling scientific case for improving the health of the public. Circulation2014;129(10):1085‐7. [DOI: 10.1161/CIRCULATIONAHA.114.008138] ">Whelton 2014</a>). In most countries, establishing means of monitoring progress, both in terms of population levels of dietary salt intake and blood pressure, will be essential. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009217-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="578Study flow diagram for review and update" data-id="CD009217-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>578Study flow diagram for review and update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009217-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009217-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/full#CD009217-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 1 All‐cause mortality at end of trial." data-id="CD009217-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 1 All‐cause mortality at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 2 All‐cause mortality at longest follow‐up." data-id="CD009217-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 2 All‐cause mortality at longest follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 3 Cardiovascular mortality at end of trial." data-id="CD009217-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 3 Cardiovascular mortality at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 4 Cardiovascular events at end of trial." data-id="CD009217-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 4 Cardiovascular events at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 5 Cardiovascular disease events at longest follow‐up." data-id="CD009217-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 5 Cardiovascular disease events at longest follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 6 Systolic blood pressure at end of trial." data-id="CD009217-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 6 Systolic blood pressure at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 7 Diastolic blood pressure at end of trial." data-id="CD009217-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 7 Diastolic blood pressure at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Reduced salt versus control, Outcome 8 Urinary sodium excretion at end of trial." data-id="CD009217-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Reduced salt versus control, Outcome 8 Urinary sodium excretion at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: individual RCTs, Outcome 1 All‐cause mortality at end of trial." data-id="CD009217-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: individual RCTs, Outcome 1 All‐cause mortality at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: individual RCTs, Outcome 2 Cardiovascular mortality at end of trial." data-id="CD009217-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: individual RCTs, Outcome 2 Cardiovascular mortality at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009217-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/urn:x-wiley:14651858:media:CD009217:CD009217-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_t/tCD009217-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: individual RCTs, Outcome 3 Cardiovascular events at end of trial." data-id="CD009217-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: individual RCTs, Outcome 3 Cardiovascular events at end of trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/media/CDSR/CD009217/image_n/nCD009217-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD009217-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Reduced salt versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.83, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3518</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.40, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3085</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All‐cause mortality at longest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3518</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.58, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.87, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Cardiovascular mortality at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.45, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cardiovascular events at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Hypertensives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cardiovascular disease events at longest follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.66, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.64, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3347</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.58, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Systolic blood pressure at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.79 [‐3.23, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.15 [‐2.32, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.14 [‐5.84, ‐2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Diastolic blood pressure at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.17 [‐2.08, ‐0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2079</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.37, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.74 [‐8.41, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Urinary sodium excretion at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐27.21 [‐49.85, ‐4.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐34.19 [‐49.61, ‐18.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.48 [‐53.68, 12.73]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Reduced salt versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009217-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis: individual RCTs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.45, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Normotensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3518</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.40, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.34, 4.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cardiovascular mortality at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.29, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Hypertensive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.29, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Cardiovascular events at end of trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Hypertensives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.57, 1.30]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis: individual RCTs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009217.pub3/references#CD009217-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009217.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009217-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009217-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009217-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD009217-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD009217-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD009217-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD009217-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009217-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ta#CD009217-note-0007">தமிழ்</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009217-note-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009217-note-0013">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009217\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009217\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009217\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009217\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009217\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7a2tKMcJ&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009217.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009217.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009217.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009217.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009217.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715696730"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009217.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715696734"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009217.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d8d6a3dac9371',t:'MTc0MDcxNTY5Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 